Cite
George JM, Kuriakose SS, Dee N, et al. Rapid Development of High-Level Resistance to Dolutegravir With Emergence of T97A Mutation in 2 Treatment-Experienced Individuals With Baseline Partial Sensitivity to Dolutegravir. Open Forum Infect Dis. 2018;5(10):ofy221doi: 10.1093/ofid/ofy221.
George, J. M., Kuriakose, S. S., Dee, N., Stoll, P., Lalani, T., Dewar, R., Khan, M. A., Rehman, M. T., Grossman, Z., Maldarelli, F., & Pau, A. K. (2018). Rapid Development of High-Level Resistance to Dolutegravir With Emergence of T97A Mutation in 2 Treatment-Experienced Individuals With Baseline Partial Sensitivity to Dolutegravir. Open forum infectious diseases, 5(10), ofy221. https://doi.org/10.1093/ofid/ofy221
George, Jomy M, et al. "Rapid Development of High-Level Resistance to Dolutegravir With Emergence of T97A Mutation in 2 Treatment-Experienced Individuals With Baseline Partial Sensitivity to Dolutegravir." Open forum infectious diseases vol. 5,10 (2018): ofy221. doi: https://doi.org/10.1093/ofid/ofy221
George JM, Kuriakose SS, Dee N, Stoll P, Lalani T, Dewar R, Khan MA, Rehman MT, Grossman Z, Maldarelli F, Pau AK. Rapid Development of High-Level Resistance to Dolutegravir With Emergence of T97A Mutation in 2 Treatment-Experienced Individuals With Baseline Partial Sensitivity to Dolutegravir. Open Forum Infect Dis. 2018 Sep 08;5(10):ofy221. doi: 10.1093/ofid/ofy221. eCollection 2018 Oct. PMID: 30568974; PMCID: PMC6172925.
Copy
Download .nbib